R

RadNet
D

RDNT

59.430
USD
-3.29
(-5.24%)
Market Closed
Volume
35,239
EPS
1
Div Yield
-
P/E
-849
Market Cap
4,399,408,980
Related Instruments
    C
    CAH
    -0.340
    (-0.27%)
    127.080 USD
    H
    HCSG
    -0.225
    (-2.09%)
    10.555 USD
    H
    HSIC
    -0.820
    (-1.05%)
    77.255 USD
    MCK
    MCK
    -5.91
    (-0.98%)
    597.72 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    P
    PDCO
    0.020
    (0.06%)
    31.070 USD
    X
    XRAY
    -0.200
    (-1.06%)
    18.740 USD
    More
News

Title: RadNet

Sector: Healthcare
Industry: Diagnostics & Research
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derivesa majority of its revenue from the Imaging center segment.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.